Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Lutz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranesA S Goetz, M W Lutz, T J Rimele, et al.
Journal of Theoretical Biology|August 21, 1996
The cubic ternary complex receptor-occupancy model. III. resurrecting efficacyJ M Weiss, P H Morgan, M W Lutz, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtypeD L Saussy, A S Goetz, K L Queen, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1995
Use of resampling techniques to estimate the variance of parameters in pharmacological assays when experimental protocols preclude independent replication: an example using Schild regressionsM W Lutz, T P Kenakin, M Corsi, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW StudyH Zou, S Luo, H Liu, et al.
The Journal of Infectious Diseases|November 24, 1999
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudineJ Gauthier, E J Bourne, M W Lutz, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1996
A mathematical model for analysis of pharmacologically induced changes in the kinetics of cardiac muscleM W Lutz, P H Morgan, T P Kenakin, et al.
Journal of Clinical Microbiology|September 17, 1999
Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudineM I Allen, J Gauthier, M DesLauriers, et al.
Neuromuscular Disorders : NMD|October 10, 2013
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptomsF L Mastaglia, A Rojana-udomsart, I James, et al.
Journal of Medicinal Chemistry|July 1, 1991
Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgeticsP L Feldman, M K James, M F Brackeen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranesA S Goetz, M W Lutz, T J Rimele, et al.
Journal of Theoretical Biology|August 21, 1996
The cubic ternary complex receptor-occupancy model. III. resurrecting efficacyJ M Weiss, P H Morgan, M W Lutz, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtypeD L Saussy, A S Goetz, K L Queen, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1995
Use of resampling techniques to estimate the variance of parameters in pharmacological assays when experimental protocols preclude independent replication: an example using Schild regressionsM W Lutz, T P Kenakin, M Corsi, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW StudyH Zou, S Luo, H Liu, et al.
The Journal of Infectious Diseases|November 24, 1999
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudineJ Gauthier, E J Bourne, M W Lutz, et al.
Journal of Pharmacological and Toxicological Methods|November 1, 1996
A mathematical model for analysis of pharmacologically induced changes in the kinetics of cardiac muscleM W Lutz, P H Morgan, T P Kenakin, et al.
Journal of Clinical Microbiology|September 17, 1999
Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudineM I Allen, J Gauthier, M DesLauriers, et al.
Neuromuscular Disorders : NMD|October 10, 2013
Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptomsF L Mastaglia, A Rojana-udomsart, I James, et al.
Journal of Medicinal Chemistry|July 1, 1991
Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgeticsP L Feldman, M K James, M F Brackeen, et al.
Pageof 2